It’s in the genes. Meet Auristone! This Singapore-founded biotech startup powers personalized healthcare solutions based on the science of how genes work (aka, epigenomics).
Now, they’ve just raised a $4M seed!
Investor check. Elev8 led the round. SEEDS Capital joined in, along with existing investor Genedant.
👩🏻⚕️ Doctor, doctor!
Their first product, EPI-CALL helps doctors and late-stage cancer patients get clinical insights and figure out the best therapy options.
They also offer other products:
💰 Money matters
They’ll be pushing for more clinical collaborations and market adoption for EPI-CALL.
Oh, and watch out, because they’ll be expanding to South Korea, Japan, and other markets too.
The newsletter that keeps you up-to-date on the top stories on tech and business in Southeast Asia. It's fun, quick and free.